Tocotrienol 200 mg + Eicosapentaenoic Acid (EPA) 120 mg + Docosahexaenoic Acid (DHA) 80 mg
Softgel Capsules
Prevents the Progression of NAFLD
As per a study conducted on 7,624 patients by ILBS (2018–19), approximately 30% of people were found to have liver disorders.
Tocotrienols
- Reduce liver enzymes and oxidative stress in NAFLD patients
- Possess antioxidant potency 40x greater than tocopherol
- Have unsaturated isoprenoid side chains for superior liver membrane penetration
Omega-3 Fatty Acids (EPA & DHA)
- Significantly reduce liver fat percentage and improve lipid profile
- Lower plasma triglycerides and non-HDL-C levels, while raising HDL-C
- Exhibit anti-inflammatory properties by downregulating NF-κB activation
Indicated In:
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Hyperlipidemia
- Obesity
- Alcoholism
Stages of Liver Health:
- Healthy Liver – Reversible
- Fatty Liver – Reversible
- NASH – Irreversible
- Cirrhosis – Irreversible
